Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models

Mareike Florek, Emanuela I. Sega, Dennis B. Leveson-Gower, Jeanette Baker, Antonia M. S. Müller, Dominik Schneidawind, Everett Meyer, Robert S. Negrin

Blood (2014) 124 (11): 1832–1842.

https://doi.org/10.1182/blood-2014-02-555128

Published: 2014

Includes: Supplemental data

Journal Articles

Mast cells suppress murine GVHD in a mechanism independent of CD4 + CD25 + regulatory T cells

Dennis B. Leveson-Gower, Emanuela I. Sega, Janet Kalesnikoff, Mareike Florek, Yuqiong Pan, Antonio Pierini, Stephen J. Galli, Robert S. Negrin

Blood (2013) 122 (22): 3659–3665.

https://doi.org/10.1182/blood-2013-08-519157

Published: 2013

Includes: Supplemental data

Journal Articles

The Inhibitory Receptor LAG-3 Is Not Essential for Regulatory T Cells Function but Influences Donor T Cell Potency in Acute Graft-Versus-Host-Disease

Emanuela I Sega, PhD, Dennis B Leveson-Gower, PhD, Mareike Florek, MD, Robert S Negrin, MD

Blood (2011) 118 (21): 1900.

https://doi.org/10.1182/blood.V118.21.1900.1900

Published: 2011

Journal Articles

A Novel Model of Pre-Emptive ECP Treatment Shows Significant Reduction of Gvhd-Related Mortality In Mice,

Mareike Florek, MD, Emanuela I Sega, PhD, Antonia MS Mueller, MD, Dennis B Leveson-Gower, PhD, Judith A Shizuru, MD PhD, Robert S Negrin, MD

Blood (2011) 118 (21): 4025.

https://doi.org/10.1182/blood.V118.21.4025.4025

Published: 2011

Journal Articles

IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease Following Bone Marrow Transplantation,

Lucrezia Colonna, PhD, Mareike Florek, MD, Dennis B Leveson-Gower, PhD, Emanuela I Sega, PhD, Robert Zeiser, M.D., Martin Buess, MD, Robert S Negrin, MD

Blood (2011) 118 (21): 4037.

https://doi.org/10.1182/blood.V118.21.4037.4037

Published: 2011

Journal Articles

Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4 + CD25 + Foxp3 + regulatory T cells

Ho-Jin Shin, Jeanette Baker, Dennis B. Leveson-Gower, Aaron T. Smith, Emanuela I. Sega, Robert S. Negrin

Blood (2011) 118 (8): 2342–2350.

https://doi.org/10.1182/blood-2010-10-313684

Published: 2011

Journal Articles

Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4–dependent mechanism

Dennis B. Leveson-Gower, Janelle A. Olson, Emanuela I. Sega, Richard H. Luong, Jeanette Baker, Robert Zeiser, Robert S. Negrin

Blood (2011) 117 (11): 3220–3229.

https://doi.org/10.1182/blood-2010-08-303008

Published: 2011

Journal Articles

Mast Cells Reduce Gvhd Severity In Allogeneic Transplantation by Reducing the Proliferation of Conventional T Cells

Dennis B Leveson-Gower, Emanuela I Sega, Janet Kalesnikoff, Mareike Florek, Stephen J Galli, Robert Negrin, MD

Blood (2010) 116 (21): 243.

https://doi.org/10.1182/blood.V116.21.243.243

Published: 2010

Journal Articles

Gvhd Severity Is Regulated by the Adoptive Transfer Low Numbers of NKT Cells by a Mechanism Distinct From CD4+CD25+ Regulatory T Cells.

Dennis Leveson-Gower, PhD, Janelle Olson, Emanuela I Sega, Jeanette Baker, Robert Zeiser, Robert Negrin

Blood (2009) 114 (22): 229.

https://doi.org/10.1182/blood.V114.22.229.229

Published: 2009

Journal Articles

Rapamycin and IL-2 Prevents Lethal Acute Graft-Versus Host Disease by Expansion of Donor Type CD4 + CD25 + Foxp3 + Regulatory T Cells.

Ho-Jin Shin, Jeanette Baker, Dennis Leveson-Gower, Emanuela I Sega, Robert Negrin

Blood (2009) 114 (22): 1334.

https://doi.org/10.1182/blood.V114.22.1334.1334

Published: 2009

Journal Articles

Functional Comparison of Freshly Isolated and Ex-Vivo Expanded CD4+CD25+Foxp3+ Regulatory T Cells in Suppressing Murine Acute GvHD

Emanuela I Sega, PhD, Dennis Leveson-Gower, PhD, Vu H. Nguyen, MD, Robert Negrin, MD

Blood (2008) 112 (11): 812.

https://doi.org/10.1182/blood.V112.11.812.812

Published: 2008

Journal Articles

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

Ryosei Nishimura, Jeanette Baker, Andreas Beilhack, Robert Zeiser, Janelle A. Olson, Emanuela I. Sega, Mobin Karimi, Robert S. Negrin

Blood (2008) 112 (6): 2563–2574.

https://doi.org/10.1182/blood-2007-06-092817

Published: 2008

Includes: Supplemental data

NARROW

Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models

Mast cells suppress murine GVHD in a mechanism independent of CD4 + CD25 + regulatory T cells

The Inhibitory Receptor LAG-3 Is Not Essential for Regulatory T Cells Function but Influences Donor T Cell Potency in Acute Graft-Versus-Host-Disease

A Novel Model of Pre-Emptive ECP Treatment Shows Significant Reduction of Gvhd-Related Mortality In Mice,

IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease Following Bone Marrow Transplantation,

Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4 + CD25 + Foxp3 + regulatory T cells

Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4–dependent mechanism

Mast Cells Reduce Gvhd Severity In Allogeneic Transplantation by Reducing the Proliferation of Conventional T Cells

Gvhd Severity Is Regulated by the Adoptive Transfer Low Numbers of NKT Cells by a Mechanism Distinct From CD4+CD25+ Regulatory T Cells.

Rapamycin and IL-2 Prevents Lethal Acute Graft-Versus Host Disease by Expansion of Donor Type CD4 + CD25 + Foxp3 + Regulatory T Cells.

Functional Comparison of Freshly Isolated and Ex-Vivo Expanded CD4+CD25+Foxp3+ Regulatory T Cells in Suppressing Murine Acute GvHD

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only